Navigation Links
EntreMed Initiates ENMD-2076 Clinical Trial in Multiple Myeloma
Date:12/9/2008

ROCKVILLE, Md., Dec. 9 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that it has initiated a Phase 1 study of ENMD-2076 in refractory multiple myeloma patients. The study will be conducted at the Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana. Dr. Sherif Farag, Associate Professor, Department of Medicine, will serve as principal investigator.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

Primary objectives for the dose escalation study include determining the maximum tolerated dose (MTD) and dose limiting toxicity (DLT) of ENMD-2076 when administered orally once a day in patients with multiple myeloma who are refractory to other drug therapy. The study will also assess the safety, tolerability, pharmacodynamic effects and activity of ENMD-2076 in this patient population.

Preclinical data supporting the clinical evaluation of ENMD-2076 alone and in combination in multiple myeloma were presented by Dr. Farag earlier this week at the American Society of Hematology Annual Meeting in San Francisco, CA. ENMD-2076 was shown to induce rapid apoptosis (cell death) in multiple myeloma cell lines in vitro. Significant dose-dependent antitumor activity with minimal toxicity was also induced in vivo when ENMD-2076 was administered as a single agent in multiple myeloma models. Combination studies with ENMD-2076 and lenalidomide (Revlimid(R)) in vitro indicated synergistic cytotoxic activity towards several human multiple myeloma cell lines. ENMD-2076 was shown, both in vitro and in vivo, to have minimal toxicity towards human and murine h
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. EntreMed to Present at ThinkEquity Partners 5th Annual Growth Conference
2. EntreMed Appoints Senior Vice President of Research and Development
3. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
4. EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study
5. EntreMed to Present at BIO CEO and Investor Conference
6. EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results
7. EntreMed Announces 2008 Corporate and Clinical Program Priorities
8. EntreMed to Present at BioCentury Future Leaders in the Biotech Industry Conference
9. EntreMed Receives Nasdaq Deficiency Notice
10. EntreMeds Kinase Inhibitor, ENMD-2076, Presented During AACR Special Session
11. EntreMed Will Not Seek Shareholder Approval for Reverse Stock Split at Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... DTS Language Services, Inc . is pleased ... Life Science organizations who need document translations. Clients will ... their documents in advance with a selection of nearly 50 ... often a critical factor in clinical and scientific fields, and ...
(Date:1/15/2014)... 15, 2014 AudioNotch is the internet's ... for the treatment of tinnitus. Patients listen to sound ... over a period of weeks to months, their tinnitus volume ... two forms: Notched Music and Notched White Noise. Now, AudioNotch ...
(Date:1/14/2014)... Carahsoft and CDS Federal Services have ... at 2pm EST (11am PST), “Natural Language Processing: Converting ... how technology can turn raw, heterogeneous data into actionable ... The online webinar will last approximately one hour. , ...
(Date:1/14/2014)... BURLINGAME, Calif. , Jan. 14, 2014 As pet owners ... no doubt many of them wrote: "Take better care of my ... and even designer clothes and top-brand carrying cases to take the ... Pet parents might also feel compelled to buy some pricey toys ...
Breaking Biology Technology:DTS Improves Efficiency for Life Science Document Translations 2Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2
... Media Resulted in Increased Yield and Quality of Insulin-Producing Islet ... ... BOTHELL, Wash., Oct. 24 BioLife Solutions,Inc. (OTC Bulletin Board: BLFS), ... products for,cells, tissues, and organs, today announced that MicroIslet Inc. (OTC,Bulletin ...
... CPC of America, Inc.,(OTC Bulletin Board: CPCF), ... in endovascular procedures, announced today that it has,entered ... to the,agreement, BC Tech will manufacture the MedClose(TM) ... device that may be,used with a biological sealant ...
... for Patients with Lung, ... Prostate, Liver and Pancreatic Cancer, SUNNYVALE, Calif., Oct. 24 ... the field of radiosurgery,announced today that treatments of extracranial tumors ... the fiscal year ending June 30, 2008. Specifically, during this,time, ...
Cached Biology Technology:BioLife Solutions HypoThermosol(R) Adopted by MicroIslet for Processing Pancreatic Islet Cells to Treat Diabetes 2BioLife Solutions HypoThermosol(R) Adopted by MicroIslet for Processing Pancreatic Islet Cells to Treat Diabetes 3BioLife Solutions HypoThermosol(R) Adopted by MicroIslet for Processing Pancreatic Islet Cells to Treat Diabetes 4CPC of America Announces Agreement with BC Tech for Manufacture of MedClose(TM) Vascular Closure System 2CPC of America Announces Agreement with BC Tech for Manufacture of MedClose(TM) Vascular Closure System 3CyberKnife System Achieves 38 Percent Growth in Extracranial Treatments During Fiscal Year 2008 2CyberKnife System Achieves 38 Percent Growth in Extracranial Treatments During Fiscal Year 2008 3CyberKnife System Achieves 38 Percent Growth in Extracranial Treatments During Fiscal Year 2008 4
(Date:7/9/2014)... in which animals can be found, concern mounts over ... increased range for a host mean new territory for ... team of UC Santa Barbara scientists, including parasitologists Ryan ... the Journal of Biogeography , Hechinger, Kuris and ... happen: Hosts may actually lose their parasites when the ...
(Date:7/9/2014)... selection for traits that are attractive to the opposite ... to mate, the tail of male peacocks being an ... Riverside have now found that sexual selection and "placentation" ... Describing the life histories of more than 150 species ... that species with placentas tend to have males that ...
(Date:7/9/2014)... crucial piece of the puzzle behind nature,s ability ... could help advance the development of artificial photosynthesis ... provided by an international collaboration of scientists led ... (Berkeley Lab) and the SLAC National Accelerator Laboratory. ... Source (LCLS), the world,s most powerful x-ray laser, ...
Breaking Biology News(10 mins):Not at home on the range 2Not at home on the range 3Not at home on the range 4Biologists link sexual selection and placenta formation 2Biologists link sexual selection and placenta formation 3Biologists link sexual selection and placenta formation 4Postcards from the photosynthetic edge 2Postcards from the photosynthetic edge 3
... that some bird species in the desert southwest are less ... through their habitat. In fact, the Baylor researchers say that ... that is formed after a fire is positive for the ... bird species in the Chihuahuan Desert scaled Quail, Loggerhead ...
... 2011. Knowing how trees grow and how they age ... a warmer climate, for instance, and other changes. Little is ... with tree growth. "Although much research has been done on ... they increase in size," says research ecologist Frederick (Rick) Meinzer, ...
... form of malignancy in adult Caucasian populations, with more than ... Lifestyle risk factors but , The ... the aging structure of Western populations, and as a result ... sun exposure, which is a key risk factor for NMSC, ...
Cached Biology News:Study finds some desert birds less affected by wildfires and climate change 2Some cutaneous HPV types may be involved in non-melanoma skin cancer development 2
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
quantitation of phosphatase activity, evaluation of hits and leads from HTS...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Request Info...
Biology Products: